Faster brain stimulation for early psychosis risk
Part of Mental health clinical trials.
This study tests a faster type of brain stimulation, called accelerated neuromodulation therapy, in people who have early signs that could lead to psychosis. The goal is to see if this treatment can help reduce symptoms and improve daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at clinical high risk for psychosis, confirmed by a special interview
- Your clinical team agrees that you are stable enough to take part
- You can give informed consent
- You are not pregnant, breastfeeding, or using an intrauterine device
- You have not had electroconvulsive therapy (ECT) in the last 6 months
- You do not have any metal implants in your head or neck, a history of seizures, a brain tumor or brain surgery, or severe heart disease
- You have never had rTMS (repetitive transcranial magnetic stimulation) before
- You do not have a documented history of significant intellectual disability
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new, faster form of brain stimulation called accelerated neuromodulation therapy can help reduce negative symptoms (like loss of motivation or social withdrawal) in people with schizophrenia. It aims to see if this treatment can improve daily functioning and quality of life.
This study tests whether a faster, brain-guided form of TMS (called iTBS) can help treat depression in teenagers better than standard TMS. You may qualify if you're 16–19, have tried an antidepressant that didn't work well, and have no medical reasons to avoid TMS or MRI.
This study tests a faster type of brain stimulation called accelerated iTBS to see if it can help with depression and suicidal thoughts. It might be an option if other treatments haven't worked.
This study tests an accelerated form of iTBS (a non-invasive brain stimulation technique) for depression that hasn't improved with antidepressant medications. The goal is to help people with major depression who haven't responded adequately to at least one antidepressant drug.
This trial tests an accelerated form of TMS (a treatment that uses magnetic pulses to stimulate the brain) for people with severe depression who have recently been in a psychiatric hospital. It aims to see if a faster schedule of TMS can help improve symptoms quickly.
This trial tests whether a non-invasive brain stimulation technique (rTMS) can improve thinking and memory in people with psychosis. It involves MRI scans and several study visits at McLean Hospital.
Hear when a new Clinical High Risk for Psychosis (CHR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.